SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Refractory obsessive-compulsive disorder: state-of-the-art treatment.
11 references·11 citing·38 second hop
Refractory obsessive-compulsive disorder: state-of-the-art treatment. (2002)Refractory obsessive-compulsive disorder:…A Double-blind, Placebo-Controlled Study of Risperidone Addition in Serotonin Reuptake Inhibitor–Refractory Obsessive-compulsive Disorder (2000)A Double-blind, Placebo-Contr…Placebo-controlled trial of fluoxetine and phenelzine for obsessive- compulsive disorder (1997)Placebo-controlled trial of f…Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study (1997)Effect of prefrontal repetiti…Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder. (1996)Risperidone augmentation of S…Inositol treatment of obsessive-compulsive disorder (1996)Inositol treatment of obsessi…Haloperidol Addition in Fluvoxamine-Refractory Obsessive-Compulsive Disorder (1994)Haloperidol Addition in Fluvo…Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder (1993)Double-blind study of adjuvan…Clomipramine, Clonazepam, and Clonidine Treatment of Obsessive-Compulsive Disorder (1992)Clomipramine, Clonazepam, and…A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy. (1991)A controlled trial of lithium…Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings (1988)Serotonergic and noradrenergi…Obsessive-Compulsive Disorder (1983)Obsessive-Compulsive DisorderPlacebo effect after prefrontal magnetic stimulation in the treatment of resistant obsessive-compulsive disorder: a randomized controlled trial (2011)Placebo effect after prefront…Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: A practical clinical trial (2011)Group cognitive-behavioral th…Symptom dimensions and subtypes of obsessive-compulsive disorder: a developmental perspective (2009)Symptom dimensions and subtyp…Duration of Untreated Illness as a Predictor of Treatment Response and Remission in Obsessive–Compulsive Disorder (2009)Duration of Untreated Illness…Symptom Subtypes of Obsessive–Compulsive Disorder: Are they Relevant for Treatment? (2008)Symptom Subtypes of Obsessive…Neurobiological basis of serotonin–dopamine antagonists in the treatment of Gilles de la Tourette syndrome (2008)Neurobiological basis of sero…Symptom Dimensions in Obsessive-Compulsive Disorder:Implications for theDSM-V (2007)Symptom Dimensions in Obsessi…Clinical features associated with treatment-resistant pediatric obsessive-compulsive disorder (2007)Clinical features associated …Reduced serotonin transporter?availability in obsessive?compulsive disorder (OCD) (2004)Reduced serotonin transporter…Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms? (2004)Do antipsychotics ameliorate …A Review of Pharmacologic Treatments for Obsessive-Compulsive Disorder (2003)A Review of Pharmacologic Tre…The Yale-Brown Obsessive Compulsive Scale (1989)World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders (2002)Effectiveness of complementary and self‐help treatments for anxiety disorders (2004)Obsessive–compulsive disorder: a critical review of therapeutic perspectives (2005)Regional Cerebral Blood Flow Measured During Symptom Provocation in Obsessive-Compulsive Disorder Using Oxygen 15—Labeled Carbon Dioxide and Positron Emission Tomography (1994)Systematic Changes in Cerebral Glucose Metabolic Rate After Successful Behavior Modification Treatment of Obsessive-Compulsive Disorder (1996)Right Prefrontal Repetitive Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder: A Double-Blind, Placebo-Controlled Study (2001)Obsessive–Compulsive Disorder (2004)Randomized sham-controlled trial of repetitive transcranial magnetic stimulation in treatment-resistant obsessive–compulsive disorder (2009)THE ASSESSMENT OF ANXIETY STATES BY RATING (1959)The Yale-Brown Obsessive Compulsive Scale (1989)Efficacy and Tolerability of Serotonin Transport Inhibitors in Obsessive-compulsive Disorder (1995)Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A quantitative Review. (1997)Development of a Rating Scale for Primary Depressive Illness (1967)Clomipramine Treatment of Obsessive-Compulsive Disorder (1980)Treatment of Endogenous Anxiety With Phobic, Hysterical, and Hypochondriacal Symptoms (1980)Obsessive-compulsive disorder and serotonin: Is there a connection? (1985)Clomipramine Hydrochloride in Childhood and Adolescent Obsessive-Compulsive Disorder—a Multicenter Trial (1992)Demographic and Clinical Features of Obsessive-Compulsive Disorder in Children and Adolescents (1995)ECDEU Assessment Manual for Psychopharmacology (1976)Treatment non-response in OCD: methodological issues and operational definitions (2002)Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment (2011)Practice Parameter for the Assessment and Treatment of Children and Adolescents With Obsessive-Compulsive Disorder (2011)Clomipramine Treatment of Childhood Obsessive-Compulsive Disorder (1985)Serotonergic Responsivity in Obsessive-Compulsive Disorder (1987)Serotonergic Responsivity in Obsessive-Compulsive Disorder (1988)Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chloro-phenylpiperazine in obsessive-compulsive disorder (1991)Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder (1991)A RATING SCALE FOR DEPRESSION (1960)Early- and late-onset obsessive–compulsive disorder in adult patients: an exploratory clinical and therapeutic study (2003)Obsessive–compulsive disorder (OCD): Practical strategies for pharmacological and somatic treatment in adults (2015)Obsessive-compulsive disorder in schizophrenia: epidemiologic and biologic overlap. (1999)Quetiapine augmentation in patients with treatment resistant obsessive???compulsive disorder: a single-blind, placebo-controlled study (2002)WCA Recommendations for the Long-Term Treatment of Obsessive-Compulsive Disorder in Adults (2003)Pharmacological Management of Treatment-Resistant Obsessive-Compulsive Disorder (2011)Pharmacotherapy of obsessive-compulsive disorder: Evidence-based treatment and beyond (2012)An Open Trial of Paroxetine in Patients With Noncombat-Related, Chronic Posttraumatic Stress Disorder (1998)Drug treatment of obsessive-compulsive disorder (2010)
this work references cited by second hop

References

  • 2000A Double-blind, Placebo-Controlled Study of Risperidone Addition in Serotonin Reuptake Inhibitor–Refractory Obsessive-compulsive Disorder571 cited
  • 1994Haloperidol Addition in Fluvoxamine-Refractory Obsessive-Compulsive Disorder570 cited
  • 1983Obsessive-Compulsive Disorder347 cited
  • 1997Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study314 cited
  • 1996Inositol treatment of obsessive-compulsive disorder209 cited
  • 1991A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy.161 cited
  • 1997Placebo-controlled trial of fluoxetine and phenelzine for obsessive- compulsive disorder155 cited
  • 1996Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder.154 cited
  • 1988Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings139 cited
  • 1992Clomipramine, Clonazepam, and Clonidine Treatment of Obsessive-Compulsive Disorder129 cited
  • 1993Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder120 cited

Cited by

  • 2011Placebo effect after prefrontal magnetic stimulation in the treatment of resistant obsessive-compulsive disorder: a randomized controlled trial111 cited
  • 2003A Review of Pharmacologic Treatments for Obsessive-Compulsive Disorder

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

108 cited
  • 2009Symptom dimensions and subtypes of obsessive-compulsive disorder: a developmental perspective106 cited
  • 2009Duration of Untreated Illness as a Predictor of Treatment Response and Remission in Obsessive–Compulsive Disorder96 cited
  • 2011Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: A practical clinical trial85 cited
  • 2004Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms?79 cited
  • 2008Neurobiological basis of serotonin–dopamine antagonists in the treatment of Gilles de la Tourette syndrome78 cited
  • 2008Symptom Subtypes of Obsessive–Compulsive Disorder: Are they Relevant for Treatment?77 cited
  • 2004Reduced serotonin transporter?availability in obsessive?compulsive disorder (OCD)76 cited
  • 2007Clinical features associated with treatment-resistant pediatric obsessive-compulsive disorder73 cited
  • 2007Symptom Dimensions in Obsessive-Compulsive Disorder:Implications for theDSM-V71 cited